Low Incidence of High-Grade Pancreatic Intraepithelial Neoplasia Lesions in a Crmp4 Gene–Deficient Mouse Model of Pancreatic Cancer

[1]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[2]  J. Holzbeierlein,et al.  CRMP4a suppresses cell motility by sequestering RhoA activity in prostate cancer cells , 2018, Cancer biology & therapy.

[3]  Jinhuan Wei,et al.  Orchestrating a biomarker panel with lncRNAs and mRNAs for predicting survival in pancreatic ductal adenocarcinoma , 2018, Journal of cellular biochemistry.

[4]  S. Cai,et al.  Targeting CRMP-4 by lentivirus-mediated RNA interference inhibits SW480 cell proliferation and colorectal cancer growth , 2016, Experimental and therapeutic medicine.

[5]  B. Xia,et al.  Collapsin response mediator protein 4 isoforms (CRMP4a and CRMP4b) have opposite effects on cell proliferation, migration, and invasion in gastric cancer , 2016, BMC Cancer.

[6]  I. Endo,et al.  Caerulein‐induced pancreatitis augments the expression and phosphorylation of collapsin response mediator protein 4 , 2016, Journal of hepato-biliary-pancreatic sciences.

[7]  R. Talukdar,et al.  NF-κB in acute pancreatitis: Mechanisms and therapeutic potential. , 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[8]  Y. Goshima,et al.  Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced mouse model of Parkinson's disease , 2016, Journal of neurochemistry.

[9]  Sumei Li,et al.  CRMP4 and CRMP2 Interact to Coordinate Cytoskeleton Dynamics, Regulating Growth Cone Development and Axon Elongation , 2015, Neural plasticity.

[10]  M. Kanda,et al.  Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor , 2015, Journal of Gastroenterology.

[11]  Y. Goshima,et al.  Crmp4 deletion promotes recovery from spinal cord injury by neuroprotection and limited scar formation , 2015, Scientific Reports.

[12]  S. Kalghatgi,et al.  Pancreatic Cancer in Chronic Pancreatitis , 2015, Indian Journal of Surgical Oncology.

[13]  G. Eibl,et al.  Risk factors for pancreatic cancer: underlying mechanisms and potential targets , 2014, Front. Physiol..

[14]  K. Gengyo-Ando,et al.  Amino- and carboxyl-terminal domains of Filamin-A interact with CRMP1 to mediate Sema3A signalling , 2014, Nature Communications.

[15]  J. Cloutier,et al.  Collapsin Response Mediator Protein 4 Regulates Growth Cone Dynamics through the Actin and Microtubule Cytoskeleton* , 2014, The Journal of Biological Chemistry.

[16]  M. Kanda,et al.  Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer , 2014, Journal of experimental & clinical cancer research : CR.

[17]  C. Thiele,et al.  Collapsin response mediator proteins: Potential diagnostic and prognostic biomarkers in cancers (Review) , 2014, Oncology letters.

[18]  R. Pirola,et al.  Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression , 2014, Front. Physiol..

[19]  K. Yanagisawa,et al.  Quantitative Proteomic Profiling Identifies DPYSL3 as Pancreatic Ductal Adenocarcinoma-Associated Molecule That Regulates Cell Adhesion and Migration by Stabilization of Focal Adhesion Complex , 2013, PloS one.

[20]  E. Ling,et al.  Dihydropyrimidinase-like 3 regulates the inflammatory response of activated microglia , 2013, Neuroscience.

[21]  I. Endo,et al.  Collapsin Response Mediator Protein 4 Expression is Associated with Liver Metastasis and Poor Survival in Pancreatic Cancer , 2013, Annals of Surgical Oncology.

[22]  S. Pandol,et al.  A starring role for stellate cells in the pancreatic cancer microenvironment. , 2013, Gastroenterology.

[23]  M. Barbacid,et al.  Genetically engineered mouse models of pancreatic adenocarcinoma , 2013, Molecular oncology.

[24]  T. Abe,et al.  CRMP4 suppresses apical dendrite bifurcation of CA1 pyramidal neurons in the mouse hippocampus , 2012, Developmental neurobiology.

[25]  M. Barbacid,et al.  What we have learned about pancreatic cancer from mouse models. , 2012, Gastroenterology.

[26]  G. Eibl,et al.  Epidemiology, risk factors, and the promotion of pancreatic cancer: Role of the stellate cell , 2012, Journal of gastroenterology and hepatology.

[27]  P. Mazur,et al.  Early requirement of Rac1 in a mouse model of pancreatic cancer. , 2011, Gastroenterology.

[28]  M. Barbacid,et al.  Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. , 2011, Cancer cell.

[29]  Toby C. Cornish,et al.  Pancreatic Intraepithelial Neoplasia. , 2011, Surgical pathology clinics.

[30]  D. He,et al.  Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer , 2010, Oncogene.

[31]  P. Maisonneuve,et al.  Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. , 2010, Best practice & research. Clinical gastroenterology.

[32]  S. Croul,et al.  Loss of collapsin response mediator Protein1, as detected by iTRAQ analysis, promotes invasion of human gliomas expressing mutant EGFRvIII. , 2009, Cancer research.

[33]  A. Masamune,et al.  Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[34]  S. Pandol,et al.  Desmoplasia of pancreatic ductal adenocarcinoma. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[35]  Y. Goshima,et al.  Semaphorin3A Signaling Mediated by Fyn-dependent Tyrosine Phosphorylation of Collapsin Response Mediator Protein 2 at Tyrosine 32* , 2009, The Journal of Biological Chemistry.

[36]  M. Korc,et al.  Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras. , 2009, Biochemical and biophysical research communications.

[37]  M. Kuo,et al.  NF-kappaB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells. , 2008, Biochemical and biophysical research communications.

[38]  J. Honnorat,et al.  Regulation of Spine Development by Semaphorin3A through Cyclin-Dependent Kinase 5 Phosphorylation of Collapsin Response Mediator Protein 1 , 2007, The Journal of Neuroscience.

[39]  D. Tuveson,et al.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion. , 2007, Cancer research.

[40]  R. Hruban,et al.  Pancreatic adenocarcinoma: update on the surgical pathology of carcinomas of ductal origin and PanINs , 2007, Modern Pathology.

[41]  M. Omary,et al.  The pancreatic stellate cell: a star on the rise in pancreatic diseases. , 2007, The Journal of clinical investigation.

[42]  Gerald C. Chu,et al.  Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. , 2006, Genes & development.

[43]  B. Eickholt,et al.  Distinct Priming Kinases Contribute to Differential Regulation of Collapsin Response Mediator Proteins by Glycogen Synthase Kinase-3 in Vivo* , 2006, Journal of Biological Chemistry.

[44]  Yoji Kawano,et al.  Phosphorylation by Rho Kinase Regulates CRMP-2 Activity in Growth Cones , 2005, Molecular and Cellular Biology.

[45]  S. Baader,et al.  Collapsin response mediator protein-4 regulates F-actin bundling. , 2005, Experimental cell research.

[46]  John A. Williams,et al.  Rho and Rac promote acinar morphological changes, actin reorganization, and amylase secretion. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[47]  R. Hruban,et al.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.

[48]  K. Mikoshiba,et al.  Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3β phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[49]  C. Hall,et al.  α2-Chimaerin, Cyclin-Dependent Kinase 5/p35, and Its Target Collapsin Response Mediator Protein-2 Are Essential Components in Semaphorin 3A-Induced Growth-Cone Collapse , 2004, The Journal of Neuroscience.

[50]  J S Wilson,et al.  Desmoplastic Reaction in Pancreatic Cancer: Role of Pancreatic Stellate Cells , 2004, Pancreas.

[51]  R. DePinho,et al.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.

[52]  E. Petricoin,et al.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.

[53]  S. Hockfield,et al.  TUC-4b, a Novel TUC Family Variant, Regulates Neurite Outgrowth and Associates with Vesicles in the Growth Cone , 2003, The Journal of Neuroscience.

[54]  Chi-Ying F. Huang,et al.  Collapsin response mediator protein-1: A novel invasion-suppressor gene , 2003, Clinical & Experimental Metastasis.

[55]  T. Yagi,et al.  Fyn and Cdk5 Mediate Semaphorin-3A Signaling, Which Is Involved in Regulation of Dendrite Orientation in Cerebral Cortex , 2002, Neuron.

[56]  K. Kaibuchi,et al.  CRMP-2 binds to tubulin heterodimers to promote microtubule assembly , 2002, Nature Cell Biology.

[57]  T. Jacks,et al.  Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. , 2001, Genes & development.

[58]  Yih-Leong Chang,et al.  Collapsin response mediator protein-1 and the invasion and metastasis of cancer cells. , 2001, Journal of the National Cancer Institute.

[59]  P. Steeg.  Collapsin response mediator protein-1: a lung cancer invasion suppressor gene with nerve. , 2001, Journal of the National Cancer Institute.

[60]  R H Hruban,et al.  Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions , 2001, The American journal of surgical pathology.

[61]  Y. Goshima,et al.  Phosphorylation of Collapsin Response Mediator Protein-2 by Rho-kinase , 2000, The Journal of Biological Chemistry.

[62]  R. Hruban,et al.  Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. , 1998, Cancer research.

[63]  M. Korsten,et al.  Periacinar stellate shaped cells in rat pancreas: identification, isolation, and culture , 1998, Gut.

[64]  S. Strittmatter,et al.  Brain CRMP Forms Heterotetramers Similar to Liver Dihydropyrimidinase , 1997, Journal of neurochemistry.

[65]  Fumio Nakamura,et al.  Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33 , 1995, Nature.

[66]  B. Necela,et al.  Mutant KRAS-induced expression of ICAM-1 in pancreatic acinar cells causes attraction of macrophages to expedite the formation of precancerous lesions. , 2015, Cancer discovery.

[67]  Yih-Leong Chang,et al.  Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. , 2010, Lung cancer.

[68]  M. Hidalgo.  Pancreatic cancer. , 2010, The New England journal of medicine.

[69]  Hua-Chien Chen,et al.  Identification of collapsin response mediator protein‐2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes , 2008, Proteomics.

[70]  Michael Goggins,et al.  Update on pancreatic intraepithelial neoplasia. , 2008, International journal of clinical and experimental pathology.

[71]  E. Furth,et al.  Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. , 2006, Cancer research.

[72]  R. Hruban,et al.  Molecular pathogenesis of pancreatic cancer. , 2006, Best practice & research. Clinical gastroenterology.

[73]  G. Adler,et al.  Hormone-induced pancreatitis. , 1992, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.